345237-74-3

Basic information

• Product Name: Ethyl 2-(4-chloro-5-Methyl-3-(trifluoroMethyl)-1H-pyrazol-1-yl)acetate
• Synonyms: SBB009395;ZINC00215757;Ethyl 2-(4-chloro-5-Methyl-3-(trifluoroMethyl)-1H-pyrazol-1-yl)acetate;(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetic acid ethyl ester;2-[4-chloro-5-methyl-3-(trifluoromethyl)-1-pyrazolyl]acetic acid ethyl ester;2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetic acid ethyl ester;BAS 01058354;BIM-0000545.P001
• CAS NO: 345237-74-3
• Molecular Formula: C9H10ClF3N2O2
• Molecular Weight: 270.6361096
• Mol File: 345237-74-3.mol

Chemical Properties

• Boiling Point: 298.9°C at 760 mmHg
• Flash Point: 134.6°C
• Appearance: /
• Density: 1.42g/cm³
• Vapor Pressure: 0.00124mmHg at 25°C
• Refractive Index: 1.491
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Ethyl 2-(4-chloro-5-Methyl-3-(trifluoroMethyl)-1H-pyrazol-1-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-(4-chloro-5-Methyl-3-(trifluoroMethyl)-1H-pyrazol-1-yl)acetate(345237-74-3)
• EPA Substance Registry System: Ethyl 2-(4-chloro-5-Methyl-3-(trifluoroMethyl)-1H-pyrazol-1-yl)acetate(345237-74-3)

Safety Data

• Hazardous Substances Data: 345237-74-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H10ClF3N2O2/c1-3-17-6(16)4-15-5(2)7(10)8(14-15)9(11,12)13/h3-4H2,1-2H3

Upstream product

• 235106-12-4 4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazole 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 378758-70-4 2-(4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetic acid 

Relevant articles and documents

ANTAGONISTS OF CHEMOKINE RECEPTORS

Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.

Thiazole-4-Carboxylic Acid Esters and Thioesters as Plant Protection Agents

The use of thiazole-4-carboxylic esters and thioesters of the formula (I) in which R1, R2, R3, R4, R5, R6, R7, Y1, Y2, Y3, W, X and G have the me

1-ARYL-4-SUBSTITUTED PIPERAZINES DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS

Compounds are provided that act as potent antagonists of the CCR1 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR1. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.